Tumour-promoting compound (TPA) enhances interferon production in chronic lymphatic leukaemia cells.
D002478:Cells, Cultured; D006801:Humans; D007369:Interferon Inducers; D007372:Interferons / Q000096:biosynthesis*; D007945:Leukemia, Lymphoid / Q000097:blood*; D008214:Lymphocytes / Q000378:metabolism; D010704:Phorbols / Q000494:pharmacology*; D013755:Tetradecanoylphorbol Acetate / Q000494:pharmacology*
D007369:Interferon Inducers; D010704:Phorbols; D007372:Interferons; D013755:Tetradecanoylphorbol Acetate